C Baumgartner Selected Research

C Baumgartner Research Topics

Disease

9	Temporal Lobe Epilepsy 06/2013 - 01/2000
7	Epilepsy (Aura) 07/2021 - 01/2000
4	Seizures (Absence Seizure) 01/2017 - 01/2000
3	Sclerosis 01/2002 - 08/2001
2	Hypothyroidism 04/2016 - 03/2014
2	Hyperthyroidism 04/2016 - 03/2013
2	Status Epilepticus (Complex Partial Status Epilepticus) 08/2015 - 12/2011
1	Anorexia 08/2018
1	Atrophy 01/2017
1	Ataxia (Dyssynergia) 01/2017
1	Hyperkinesis 01/2017
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2017
1	Encephalitis (Encephalitis, Rasmussen) 01/2017
1	Autoimmune Diseases of the Nervous System 01/2017
1	Drug Resistant Epilepsy 05/2016
1	Thrombosis (Thrombus) 04/2016
1	Sudden Infant Death (SID) 03/2013
1	Cardiac Arrhythmias (Arrythmia) 10/2012
1	Cytopenia 01/2010
1	Infections 12/2009
1	Weight Loss (Weight Reduction) 12/2009
1	Pleural Effusion (Pleural Effusions) 12/2009
1	Body Weight (Weight, Body) 12/2009
1	Systemic Mastocytosis 11/2009
1	Iron Overload 05/2009
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2009
1	Febrile Seizures (Febrile Seizure) 03/2009
1	Myeloid Leukemia (Leukemia, Myelocytic) 03/2009
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2009
1	Idiopathic Generalized Epilepsy 12/2006
1	Partial Epilepsies (Epilepsy, Partial) 11/2006
1	Marfan Syndrome (Marfan's Syndrome) 01/2005
1	Postoperative Pain 09/2003
1	Patent Ductus Arteriosus 09/2003
1	Pulmonary Valve Stenosis (Pulmonary Stenosis) 09/2003
1	Heart Failure 08/2003
1	Mesothelioma 02/2003
1	Pericardial Effusion 02/2003
1	Hepatitis 04/2001
1	Pain (Aches) 01/2001
1	Fibromyalgia (Fibrositis) 01/2001

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 07/2021 - 01/2001
2	Thyroxine (Levothyroxine)FDA LinkGeneric 04/2016 - 03/2014
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2011 - 09/2004
2	Neuropeptide YIBA 01/2002 - 08/2001
2	ChromograninsIBA 08/2001 - 01/2000
2	secretoneurinIBA 08/2001 - 01/2000
1	Nonesterified Fatty Acids (NEFA)IBA 08/2018
1	AntibodiesIBA 01/2017
1	Immunoglobulin G (IgG)IBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 04/2016
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 04/2016
1	Thyroid HormonesIBA 04/2016
1	Poloxamer (Poloxamer 407)IBA 03/2013
1	LecithinsIBA 03/2013
1	Methimazole (Thiamazole)FDA LinkGeneric 03/2013
1	Verapamil (Calan)FDA LinkGeneric 12/2011
1	Ferritins (Ferritin)IBA 01/2010
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2010
1	Immunosuppressive Agents (Immunosuppressants)IBA 12/2009
1	Imatinib Mesylate (Gleevec)FDA Link 12/2009
1	Dasatinib (BMS 354825)FDA Link 12/2009
1	midostaurinIBA 11/2009
1	IronIBA 05/2009
1	Deferasirox FDA Link 05/2009
1	Sodium Channels (Sodium Channel)IBA 03/2009
1	bcr-abl Fusion ProteinsIBA 03/2009
1	bosutinibIBA 03/2009
1	Phosphotransferases (Kinase)IBA 03/2009
1	Immunoglobulin E (IgE)IBA 12/2006
1	Chloride Channels (Chloride Channel)IBA 11/2006
1	Proteins (Proteins, Gene)FDA Link 06/2006
1	Fibrillin-1IBA 01/2005
1	Acyl Coenzyme A (Acyl CoA)IBA 12/2004
1	EnzymesIBA 12/2004
1	HydrolasesIBA 12/2004
1	beta-Adrenergic Receptor KinasesIBA 08/2003
1	Carrier Proteins (Binding Protein)IBA 08/2003
1	phosducinIBA 08/2003
1	beta-adrenergic receptor kinase inhibitory peptideIBA 08/2003
1	Cisplatin (Platino)FDA LinkGeneric 02/2003
1	CalciumIBA 01/2002
1	Calcium Channels (Calcium Channel)IBA 01/2002
1	PlasticsIBA 08/2001
1	Anticonvulsants (Antiepileptic Drugs)IBA 08/2001
1	Dynorphins (Dynorphin)IBA 08/2001
1	Chromogranin BIBA 08/2001
1	Chromogranin AIBA 08/2001
1	Ibuprofen (Motrin)FDA LinkGeneric 04/2001
1	Tropisetron (Navoban)IBA 01/2001
1	Therapeutic UsesIBA 01/2001

Therapy/Procedure

3	Electrodes (Electrode) 01/2017 - 01/2000
3	Critical Care (Surgical Intensive Care) 01/2017 - 08/2015
2	Therapeutics 03/2009 - 01/2000
2	Pericardiectomy 09/2003 - 02/2003
2	Drug Therapy (Chemotherapy) 02/2003 - 01/2000
1	Immunotherapy 01/2017
1	Vagus Nerve Stimulation 05/2016
1	Cryosurgery 10/2012
1	Thoracotomy 09/2003